---
title: "Qualigen Therapeutics (QLGN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/QLGN.US/norm.md"
symbol: "QLGN.US"
name: "Qualigen Therapeutics"
parent: "https://longbridge.com/en/quote/QLGN.US.md"
datetime: "2026-03-03T14:13:57.960Z"
locales:
  - [en](https://longbridge.com/en/quote/QLGN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/QLGN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/QLGN.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/QLGN.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/QLGN.US/norm.md)


# Qualigen Therapeutics (QLGN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -4.68 | -1.00 | -1.82 | -1.09 | -4.70 |
| ROE | 1164.84% | 186.61% | 363.28% | 132.22% | 227.04% |
| Revenue | - | - | - | - | - |
| Net income | -2.91M | -1.69M | -2.65M | -855823.00 | -1.82M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 43.47M | 3.96M | 2.85M | 4.69M | 2.31M |
| Leverage | 1.13 | -2.40 | 85.94 | 1.75 | -1.08 |
| BVPS | 0.8004 | -2.72 | -1.72 | -4.12 | -3.90 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.14M | -1.10M | -1.59M | -2.27M | -1.80M |
| Investing CF | -291000.00 | -1.21M | -305000.00 | -1.01M | -1.25M |
| Financing CF | 40.88M | 2.61M | 750000.00 | 4.06M | 3.32M |
| Free CF | -2.62M | -1.67M | -921654.00 | -3.20M | -2.40M |